Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
12/2006
12/06/2006CN1874777A 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
12/06/2006CN1872851A Compound of alpha ¿C methylene ¿C gamma ¿C butyrolactone, preparation method, and method
12/06/2006CN1872726A Method for treating wastewater from furfural production
12/06/2006CN1288142C 3-substituted phenyl-benzo furanone stabilizer and preparing process thereof
12/06/2006CN1287783C Application of probuco monoester in treating angiocardiopathy and inflammatory disease
12/05/2006US7145025 Structural carotenoid analogs for the inhibition and amelioration of disease
12/05/2006US7145021 Analogs of terpene trilactones from Ginkgo biloba and related compounds and uses thereof
12/05/2006US7145015 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain that latter as well as their use for the production of pharmaceutical agents
12/05/2006US7144909 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
12/05/2006US7144897 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
12/05/2006US7144893 4-aryl quinols and analogs thereof as therapeutic agents
12/05/2006US7144888 Vanilloid receptor ligands and their use in treatments
12/05/2006US7144885 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
12/05/2006US7144883 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders
12/05/2006US7144881 2-(2-fluoro-phenyl)-cyclopropanecarboxylic acid[1-(2,3-dihydro-benzofuran-5-yl)-ethyl]-amide for example; for pain, migraine, neuropathic pain, bipolar disorders, convulsions, mania, epilepsy, anxiety, depression and neurodegenerative disorders
12/05/2006CA2396458C Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
12/03/2006CA2547744A1 Linear dicationic terphenyls and their aza analogues as antiparasitic agents
11/2006
11/30/2006WO2006127184A1 Process for preparation of sulfamide derivatives
11/30/2006WO2006125812A1 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament
11/30/2006WO2006125728A1 Preparation of (s)-4-fluoromethyl-dihydro-furan-2-one
11/30/2006WO2006125687A1 Heteroaroyl-substituted serine amides
11/30/2006WO2006125397A1 Nonsteroic androgen acceptor regulators, preparation process, pharmaceutical composition and use thereof
11/30/2006WO2006079112A3 Enantioselective synthesis of merrilactone a and its analogs
11/30/2006WO2006055625A3 Heterocyclylbiphenyl derivates as protein tyrosine phosphatase inhibitors
11/30/2006US20060270726 Phenyl substituted cyclic derivatives
11/30/2006US20060270651 Antibacterial agents
11/30/2006DE102005023437A1 Verbindungen für organische elektronische Vorrichtungen Compounds for organic electronic devices
11/30/2006CA2609243A1 Heteroaroyl-substituted serine amides
11/30/2006CA2609185A1 Process for preparation of sulfamide derivatives
11/30/2006CA2607927A1 Preparation of (s)-4-fluoromethyl-dihydro-furan-2-one
11/30/2006CA2604165A1 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament
11/29/2006EP1726589A2 5,5'-bis-(4-amidinophenyl)-2,2'-bifuran derivatives and related compounds as antiprotozoal agent and prodrugs thereof
11/29/2006EP1726582A2 Compounds and methods for the inhibition of the expression of vcam-1
11/29/2006EP1726580A1 Aminophenylpropanoic acid derivative
11/29/2006EP1725524A1 Substituted heteroaryl- and phenylsulfamoyl compounds
11/29/2006EP1725236A1 Novel m3 muscarinic acetylcholine receptor antagonists
11/29/2006EP1458791B1 Methods for the preparation of poly(etherimides)s
11/29/2006EP1239886B1 Labelled ascorbic acid derivatives
11/29/2006EP1187805B1 Process for preparing r-(-)-carnitine from s-(-)-chlorosuccinic acid or from a derivative thereof
11/29/2006EP1076053B1 3-arylphenyl sulfide derivatives and insecticides and miticides
11/29/2006CN1871226A Dihydrobenzofuranyl alkanamines and pharmaceutical compositions containing them
11/29/2006CN1871220A 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms
11/29/2006CN1871219A Hexylcarboxanilide
11/29/2006CN1871218A Isopentyl carboxanilides for combating undesired micro-organisms
11/29/2006CN1871194A Homogeneous process for the hydrogenation of dicarboxylic acids and/or anhydrides thereof
11/29/2006CN1869035A Lactone monomer compound and its application in preparing medicine for treating cancer
11/29/2006CN1869031A Lactone monomer compound and its application in preparing anticancer medicine
11/29/2006CN1286845C Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (HBV)
11/29/2006CN1286840C Isopentenyl xanthone compounds and their use in the preparation of antitumor medicines
11/29/2006CN1286829C Method of preparing gamma butyrolactone and tetrahydropyrane from 1,4-butanediol
11/29/2006CN1286809C Arylphenyl-substituted cyclic ketoenols compound
11/28/2006US7141706 Protected and unprotected triols for prostaglandin synthesis
11/28/2006US7141682 Liquid phase synthesis of methylene lactones using oxnitride catalyst
11/28/2006US7141609 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/28/2006US7141604 Administering to a patient citalopram or salts to treat hypertension and hypotension
11/28/2006CA2375513C 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
11/28/2006CA2164633C Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia
11/28/2006CA2113603C Tricyclic condensed heterocyclic compounds, their production and use
11/23/2006WO2006125208A1 Inhibitors of matrix metalloproteinases
11/23/2006WO2006124861A2 Benzofuran compounds
11/23/2006WO2006123473A1 (meth)acryloyloxytetrahydrofurans and process for production thereof
11/23/2006WO2006063287B1 Conversion of 2,5-(hydroxymethyl) furaldehyde to 2,5-bis (hydroxymethyl) tetrahydofuran, purification and industrial uses of the product
11/23/2006WO2006061372A3 Phenylpiperazines with a combination of affinity for dopamine -d2 receptors and serotonin reuptake sites
11/23/2006US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/23/2006US20060264653 Aminoacetonitrile derivatives and their use for controlling parasites
11/23/2006US20060264641 Process for preparing 3-heteroaryl-3-hydroxypropanoic acid derivatives
11/23/2006US20060264618 Protease inhibitor conjugates and antibodies useful in immunoassay
11/23/2006US20060264483 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
11/23/2006US20060264471 3-(cyclopenten-1-yl)-benzyl-or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derviatives and use thereof as medicines for treating schizophrenia
11/23/2006US20060264435 Novel compounds
11/23/2006US20060264424 Arylsulfonamidobenzylic compounds
11/23/2006US20060264412 Carbonylation; hydrogenation; for preparation of eplerenone
11/23/2006DE60202452C5 Pyridazinonaldose reductase inhibitoren Reductase inhibitors Pyridazinonaldose
11/23/2006DE19702279B4 3,5,5-Trimethylcyclohexanone 3,5,5-trimethylcyclohexanone
11/22/2006EP1724013A1 Asymmetric reaction catalyst and process for production of optically active compounds with the same
11/22/2006EP1723133A1 One pot synthesis of citalopram from 5-cyanophthalide
11/22/2006EP1723132A1 Ep2 receptor agonists
11/22/2006EP1723131A1 Crystalline polymorphs of a cxc-chemokine receptor ligand
11/22/2006EP1723102A2 N-substituted benzene sulfonamides
11/22/2006EP1723097A1 Ester derivatives of rhein and their therapeutic use
11/22/2006EP1722779A1 Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents
11/22/2006EP1532129B1 Sorbicillactone-a derivatives for the treatment of tumour and viral diseases
11/22/2006EP1501815B1 Substituted phenylacetamides and their use as glucokinase activators
11/22/2006EP1467982B1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
11/22/2006EP1268412B1 Sulphonamido-substituted bridged bicycloalkyl derivatives
11/22/2006EP1244651B1 Diamidine compounds as dna minor groove binders
11/22/2006CN1867557A Substitute thiophenes and uses therof
11/22/2006CN1865256A 6,7-dihydroligustilide and alkylidene phthalide synthesis method
11/22/2006CN1865219A 2- and 2,5-substituted phenylketo-enols
11/22/2006CN1865214A Method for producing aromatic carboxylic acid using nitrogen oxide as catalytic additive
11/22/2006CN1285597C 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
11/22/2006CN1285585C Method for separation purification of sclareolide from synthetic sclareol composites
11/22/2006CN1285584C Process for the preparation of ascorbic acid
11/22/2006CN1285572C Cannabinod receptor ligands
11/21/2006US7138533 acetylcholinesterase inhibitory action and an alpha 1 antagonistic action
11/21/2006US7138432 Arylsulfonamido-substituted hydroxamic acid derivatives
11/21/2006US7138414 Antidiabetic agents
11/21/2006US7138411 Substituted benzopyran derivatives for the treatment of inflammation
11/21/2006US7138400 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
11/21/2006US7138368 3S,3aR,7aR-6-isopropyl-1,1,3,3a-tetramethyl-1,3,3,9,4,7,7a-hexahydroisobenzofuran; useful for perfuming soaps, shower or bath gels, hygiene products, hair care products, body deodorants, air freshners or cosmetic preperation